Found vs Hims & Hers

What we like

• Both compounded vials and FDA-approved brand pens on one account, so an on-label option stays open for an OB conversation
• Price stays the same at every dose — the budget doesn't move under you at each titration step
• Clinical visits route through major insurers at around a $30 copay, with a flat $50/mo Medicare Part D tier — close to unique on this roster

The caveats

• –The $99 and $169 headlines both require twelve months paid up front; month to month it is $299 cash pay, or about $199 with insurance
• –A video appointment is mandatory for every refill, through the mobile app — a standing commitment, not an async refill
• –Labs are explicitly excluded from every plan and billed separately, and brand-name pens are billed on top of the membership

What we like

• Now selling FDA-approved brand-name medication (Wegovy, Zepbound, Ozempic) rather than compounded semaglutide
• An explicit women's entrance (Hers) and a polished nationwide app most mothers already trust
• Oral and injectable routes, so a needle-averse first-timer has a way in

The caveats

• –The posted 'from $149/mo' price is medication only — a required $149/mo membership (billed separately, $39 the first month) roughly doubles the real ongoing cost
• –Carries FDA warning letters dated 9 September 2025 over the prior compounded-semaglutide business, before this pivot to brand-name product
• –A volume-first model — ongoing clinical touch is lighter than a dedicated care team